Since the tryptase and chymase expressing MC phenotype, MCTC, increases in patients with chronic respiratory disease, including in the alveolar parenchyma in patients with asthma [2], it might indicate a detrimental role for MCTC with regard to uPAR/suPAR expression and release. Here, CMA1 is linked to asthma.